diazepam

diazepam
Name	Diazepam
Tradename	Valium, Diastat, others
Drugs	Benzodiazepine
Routes	Oral, intravenous, intramuscular, rectal, intranasal
Legalstatus	Varies by country
Metabolism	Hepatic (CYP2C19, CYP3A4)
Elimination	Renal

diazepam

Diazepam is a benzodiazepine medication widely used for short-term management of anxiety, seizures, muscle spasms, and alcohol withdrawal. It acts rapidly and has a relatively long elimination half-life, contributing to its inclusion on many national essential medicines lists and formularies. Numerous hospitals, clinics, and emergency medical services worldwide include the drug in treatment protocols for acute agitation and convulsive status epilepticus.

Medical uses

Diazepam is prescribed for acute anxiety and panic attacks in emergency departments at institutions such as Mayo Clinic, Cleveland Clinic, and large university hospitals associated with Johns Hopkins Hospital, Massachusetts General Hospital, and Charité – Universitätsmedizin Berlin. It is used as an anticonvulsant for seizure clusters and status epilepticus in settings including World Health Organization emergency kits and prehospital care by American Heart Association-aligned emergency medical services. Diazepam serves as a skeletal muscle relaxant in cases of spasticity related to conditions managed at centers like Sheffield Teaching Hospitals NHS Foundation Trust and Toronto General Hospital, and for sedation during procedures at surgical centers affiliated with Stanford Health Care and Mount Sinai Health System. It is also applied for alcohol withdrawal management per protocols influenced by guidelines from National Institute for Health and Care Excellence and Substance Abuse and Mental Health Services Administration.

Pharmacology

Diazepam enhances inhibitory neurotransmission by modulating the gamma-aminobutyric acid type A receptor, a mechanism investigated in laboratories at institutions such as Salk Institute for Biological Studies, Cold Spring Harbor Laboratory, and the Max Planck Institute for Brain Research. Metabolism occurs in the liver via cytochrome P450 enzymes including CYP2C19 and CYP3A4, studied in pharmacology departments at University of Oxford, Harvard Medical School, and Imperial College London. Active metabolites such as nordiazepam contribute to pharmacokinetics characterized in clinical pharmacology trials conducted at National Institutes of Health and pharmaceutical research centers at companies like Roche and Hoffmann-La Roche. The drug’s onset and duration inform dosing regimens used in anesthesia suites at Royal Adelaide Hospital and intensive care units at Guy's and St Thomas' NHS Foundation Trust.

Adverse effects and safety

Common adverse effects include sedation and impaired coordination, considerations emphasized by professional bodies like American Medical Association, Royal College of Physicians, and European Medicines Agency. Prolonged use can lead to tolerance, dependence, and withdrawal syndromes noted in reports from Centers for Disease Control and Prevention, World Health Organization, and addiction research centers at Beth Israel Deaconess Medical Center. Cognitive impairment and increased fall risk have prompted safety advisories from elderly care institutions such as National Health Service (England) geriatric services and long-term care providers like Veterans Health Administration. Case series from neurology departments at Mayo Clinic and Johns Hopkins Hospital describe respiratory depression when combined with central nervous system depressants.

Interactions and contraindications

Diazepam interacts pharmacokinetically and pharmacodynamically with other medications metabolized by CYP3A4 and CYP2C19 as reviewed by formularies at U.S. Food and Drug Administration, European Medicines Agency, and drug information centers at University of California, San Francisco Medical Center. Concomitant use with opioids, including agents produced by Pfizer, Johnson & Johnson, and GSK, increases risk of fatal respiratory depression, leading to boxed warnings and guidance from regulatory agencies such as the U.S. Food and Drug Administration and safety committees at World Health Organization. Contraindications in acute-angle glaucoma and severe respiratory insufficiency are noted in clinical guidelines from ophthalmology departments at Moorfields Eye Hospital and respiratory services at Royal Brompton Hospital. Special caution is advised in pregnancy and breastfeeding per guidance from American College of Obstetricians and Gynecologists and teratology research centers at National Birth Defects Prevention Study collaborators.

History and society

Diazepam was developed in the mid-20th century by chemists at Hoffmann-La Roche and introduced to the market during a period of rapid psychopharmacological innovation alongside drugs studied at Eli Lilly and Company and SmithKline Beecham. Its marketing campaigns and social impact were documented in cultural histories alongside figures from 1960s counterculture and policy debates influenced by legislation such as narcotics and controlled substances acts in countries like the United States and United Kingdom. Public health responses to misuse involved institutions including National Institute on Drug Abuse, SAMHSA, and harm-reduction programs in cities like London, New York City, and Sydney. Litigation and regulatory reviews have involved legal teams and courts such as the Supreme Court of the United States and national regulatory tribunals in Germany and France.

Formulations and availability

Diazepam is available in multiple formulations—oral tablets, rectal gels, intravenous solutions, and intranasal sprays—supplied by pharmaceutical manufacturers including Hoffmann-La Roche, Teva Pharmaceutical Industries, and regional generic producers distributed through hospital pharmacies at Karolinska University Hospital and community pharmacies part of chains like Boots UK and Walgreens. Its inclusion on the World Health Organization Model List of Essential Medicines influences procurement by ministries of health in countries such as India, South Africa, and Brazil. Regulatory approval, scheduling, and prescription requirements vary across jurisdictions overseen by agencies like the U.S. Food and Drug Administration, European Medicines Agency, and national health authorities in Canada, Japan, and Australia.

Category:Drugs